Search

Your search keyword '"Uchida, Masatoshi"' showing total 44 results
Start Over Author "Uchida, Masatoshi"
44 results on '"Uchida, Masatoshi"'

1. Impact of Lactate Clearance on Clinical and Neurological Outcomes of Patients With Out-of-Hospital Cardiac Arrest Treated With Extracorporeal Cardiopulmonary Resuscitation: A Secondary Data Analysis*

Author

Sugimoto, Momoko, Takayama, Wataru, Inoue, Akihiko, Hifumi, Toru, Sakamoto, Tetsuya, Kuroda, Yasuhiro, Otomo, Yasuhiro, Senda, Asae, Suzuki, Hajime, Tanimoto, Atsunori, Kitagawa, Kanta, Katayama, Yoichi, Igarashi, Nobuaki, Kawano, Masayuki, Kuroki, Yuji, Umehara, Tadashi, Sasaki, Yukari, Tominaga, Naoki, Hamaguchi, Takuro, Sakai, Takuma, Abe, Takeru, Hanafusa, Hiroaki, Yamaoka, Yuki, Kakizaki, Yumi, Sakato, Shinya, Kashiwabara, Shiho, Kadoya, Takashi, Misumi, Kayo, Kobayashi, Takaomi, Yamada, Sou, Kobayashi, Masakazu, Akashi, Naoko, Kuno, Masamune, Maruyama, Jun, Kobata, Hitoshi, Soh, Mitsuhito, Shirasaki, Kasumi, Shiba, Daiki, Isokawa, Shutaro, Uchida, Masatoshi, Sakurai, Atsushi, Tatsukawa, Hirotaka, Nishikawa, Marie, Kojima, Mitsuaki, Kosaki, Ryohei, Shimazui, Takashi, Kinoshita, Hiroki, Sawada, Yusuke, Yamamoto, Ryo, Masuzawa, Yuya, Matsumura, Kazuki, and Shimazaki, Junya

Published
2024
Full Text
View/download PDF

7. Development and validation of the predictive risk of death model for adult patients admitted to intensive care units in Japan: an approach to improve the accuracy of healthcare quality measures

Author

Endo, Hideki, Uchino, Shigehiko, Hashimoto, Satoru, Aoki, Yoshitaka, Hashiba, Eiji, Hatakeyama, Junji, Hayakawa, Katsura, Ichihara, Nao, Irie, Hiromasa, Kawasaki, Tatsuya, Kumasawa, Junji, Kurosawa, Hiroshi, Nakamura, Tomoyuki, Ohbe, Hiroyuki, Okamoto, Hiroshi, Shigemitsu, Hidenobu, Tagami, Takashi, Takaki, Shunsuke, Takimoto, Kohei, Uchida, Masatoshi, and Miyata, Hiroaki

Published
2021
Full Text
View/download PDF

8. Conventional risk prediction models fail to accurately predict mortality risk among patients with coronavirus disease 2019 in intensive care units: a difficult time to assess clinical severity and quality of care

Author

Endo, Hideki, Ohbe, Hiroyuki, Kumasawa, Junji, Uchino, Shigehiko, Hashimoto, Satoru, Aoki, Yoshitaka, Asaga, Takehiko, Hashiba, Eiji, Hatakeyama, Junji, Hayakawa, Katsura, Ichihara, Nao, Irie, Hiromasa, Kawasaki, Tatsuya, Kurosawa, Hiroshi, Nakamura, Tomoyuki, Okamoto, Hiroshi, Shigemitsu, Hidenobu, Takaki, Shunsuke, Takimoto, Kohei, Uchida, Masatoshi, Uchimido, Ryo, and Miyata, Hiroaki

Published
2021
Full Text
View/download PDF

10. Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan

Author

Abe, Toshikazu, Ogura, Hiroshi, Kushimoto, Shigeki, Shiraishi, Atsushi, Sugiyama, Takehiro, Deshpande, Gautam A., Uchida, Masatoshi, Nagata, Isao, Saitoh, Daizoh, Fujishima, Seitaro, Mayumi, Toshihiko, Hifumi, Toru, Shiino, Yasukazu, Nakada, Taka-aki, Tarui, Takehiko, Otomo, Yasuhiro, Okamoto, Kohji, Umemura, Yutaka, Kotani, Joji, Sakamoto, Yuichiro, Sasaki, Junichi, Shiraishi, Shin-ichiro, Takuma, Kiyotsugu, Tsuruta, Ryosuke, Hagiwara, Akiyoshi, Yamakawa, Kazuma, Masuno, Tomohiko, Takeyama, Naoshi, Yamashita, Norio, Ikeda, Hiroto, Ueyama, Masashi, Fujimi, Satoshi, Gando, Satoshi, and on behalf of JAAM FORECAST group

Published
2019
Full Text
View/download PDF

11. Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for adult convulsive status epilepticus: a multicentre non-inferiority randomised control trial

Author

Nakamura, Kensuke, primary, Marushima, Aiki, additional, Takahashi, Yuji, additional, Mochizuki, Masaki, additional, Kimura, Akio, additional, Fukuda, Yu, additional, Asami, Masahiro, additional, Nakamoto, Hidetoshi, additional, Egawa, Satoshi, additional, Kaneko, Junya, additional, Unemoto, Kyoko, additional, Kondo, Yutaka, additional, Yonekawa, Chikara, additional, Uchida, Masatoshi, additional, Hoshiyama, Eisei, additional, Yamada, Takeshi, additional, Maruo, Kazushi, additional, Ishikawa, Eiichi, additional, Matsumaru, Yuji, additional, and Inoue, Yoshiaki, additional

Published
2022
Full Text
View/download PDF

15. Additional file 1 of Characteristics of patients who received helicopter emergency medical services in Japan from 2012 to 2019: a retrospective analysis of data from Tochigi Prefecture

Author

Wake, Koji, Noguchi, Takafumi, Hishinuma, Hidekazu, Zaitsu, Masayoshi, Kikuchi, Jin, Uchida, Masatoshi, Hayashi, Kentaro, Machida, Masanari, Houzumi, Hajime, Hoshiyama, Eisei, Takahashi, Kyo, Kobashi, Gen, and Ono, Kazuyuki

Abstract

Additional file 1. Table S1: Demographics and clinical characteristics of patients across different modes and types of transport. This data represents the 5163 patient cases treated by the Tochigi Helicopter Emergency Medical Services. In addition to Table 2 in the main text, the different characteristics of patients who were transported to the base hospital and to other hospitals are further described in this data. Table S2: Demographics and characteristics of patients (N = 2924) transported to the base hospital by the Tochigi helicopter emergency medical service. This is the data of 2924 cases of patients transported to the base hospital. In addition to Table 2 in the main text, short-term clinical outcomes are described in this data. Table S3: International variations of backgrounds and outcomes of helicopter emergency medical services. This data briefly summarizes international reports of the backgrounds and outcomes of helicopter emergency medical services.

Published
2022
Full Text
View/download PDF

16. Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for adult convulsive status epilepticus: a multicentre non-inferiority randomised control trial

Author

Nakamura, Kensuke, Marushima, Aiki, Takahashi, Yuji, Mochizuki, Masaki, Kimura, Akio, Fukuda, Yu, Asami, Masahiro, Nakamoto, Hidetoshi, Egawa, Satoshi, Kaneko, Junya, Unemoto, Kyoko, Kondo, Yutaka, Yonekawa, Chikara, Uchida, Masatoshi, Hoshiyama, Eisei, Yamada, Takeshi, Maruo, Kazushi, Ishikawa, Eiichi, Matsumaru, Yuji, and Inoue, Yoshiaki

Abstract

ObjectiveStatus epilepticus (SE) is an emergency condition for which rapid and secured cessation is crucial. Although fosphenytoin (FPHT) is recommended as a second-line treatment, levetiracetam (LEV) reportedly has similar efficacy, but higher safety. Therefore, we herein compared LEV with FPHT in adult SE.MethodsWe initiated a multicentre randomised control trial in emergency departments with adult patients with convulsive SE. Diazepam was initially administered, followed intravenously by FPHT at 22.5 mg/kg or LEV at 1000–3000 mg. The primary outcome was assigned as the seizure cessation rate within 30 min of the administration of the study drug.ResultsA total of 176 adult patients with SE were enrolled (82 FPHT and 94 LEV), and 3 were excluded from the full analysis set. Seizure cessation rates within 30 min were 83.8% (67/80) in the FPHT group and 89.2% (83/93) in the LEV group. The difference in these rates was 5.5% (95% CI −4.7 to 15.7, p=0.29). The non-inferiority of LEV to FPHT was confirmed with p<0.001 by the Farrington-Manning test. No significant differences were observed in the seizure recurrence rate or intubation rate within 24 hours. Serious adverse events developed in three patients in the FPHT group and none in the LEV group (p=0.061).ConclusionThe efficacy of LEV was similar to that of FPHT for adult SE following the administration of diazepam. LEV may be recommended as a second-line treatment for SE along with phenytoin/FPHT.Trial registration numberjRCTs031190160.

Published
2023
Full Text
View/download PDF

17. Additional file 1 of Development and validation of the predictive risk of death model for adult patients admitted to intensive care units in Japan: an approach to improve the accuracy of healthcare quality measures

Author

Endo, Hideki, Shigehiko Uchino, Hashimoto, Satoru, Aoki, Yoshitaka, Hashiba, Eiji, Hatakeyama, Junji, Hayakawa, Katsura, Ichihara, Nao, Irie, Hiromasa, Kawasaki, Tatsuya, Kumasawa, Junji, Kurosawa, Hiroshi, Nakamura, Tomoyuki, Ohbe, Hiroyuki, Okamoto, Hiroshi, Hidenobu Shigemitsu, Tagami, Takashi, Takaki, Shunsuke, Takimoto, Kohei, Uchida, Masatoshi, and Miyata, Hiroaki

Abstract

Additional file 1: Table S1 Coefficients of models 1 and 2. R code for fitting models 1, 2, and 3. Fig. S1 EWMA charts for the 44 ICUs (recalibrated with the method used in model 3). Sequential admissions are presented on the x-axis. The red lines show the exponentially weighted moving average of mortality, with starting points of the average mortality in each ICU during the study period and with a weight of 0.005 on the latest data. The light and dark green lines are the control limits representing two- and three-standard deviations, respectively. EWMA, exponentially weighted moving average; ICU, intensive care unit

Published
2021
Full Text
View/download PDF

18. Levetiracetam Versus Fosphenytoin as a Second-Line Treatment After Diazepam for Adult Status Epilepticus: A Multicenter Non-Inferiority Randomized Control Trial

Author

Nakamura, Kensuke, primary, Marushima, Aiki, additional, Takahashi, Yuji, additional, Mochizuki, Masaki, additional, Kimura, Akio, additional, Fukuda, Yu, additional, Asami, Masahiro, additional, Nakamoto, Hidetoshi, additional, Egawa, Satoshi, additional, Kaneko, Junya, additional, Unemoto, Kyoko, additional, Kondo, Yutaka, additional, Yonekawa, Chikara, additional, Uchida, Masatoshi, additional, Hoshiyama, Eisei, additional, Yamada, Takeshi, additional, Maruo, Kazushi, additional, Ishikawa, Eiichi, additional, Matsumaru, Yuji, additional, Inoue, Yoshiaki, additional, and Study Group, IENE ECT with the LIFE, additional

Published
2021
Full Text
View/download PDF

21. Additional file 1: of Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan

Author

Abe, Toshikazu, Ogura, Hiroshi, Kushimoto, Shigeki, Shiraishi, Atsushi, Sugiyama, Takehiro, Deshpande, Gautam, Uchida, Masatoshi, Nagata, Isao, Daizoh Saitoh, Seitaro Fujishima, Mayumi, Toshihiko, Hifumi, Toru, Shiino, Yasukazu, Taka-Aki Nakada, Tarui, Takehiko, Otomo, Yasuhiro, Okamoto, Kohji, Umemura, Yutaka, Kotani, Joji, Sakamoto, Yuichiro, Sasaki, Junichi, Shin-Ichiro Shiraishi, Takuma, Kiyotsugu, Tsuruta, Ryosuke, Hagiwara, Akiyoshi, Yamakawa, Kazuma, Masuno, Tomohiko, Naoshi Takeyama, Yamashita, Norio, Ikeda, Hiroto, Ueyama, Masashi, Fujimi, Satoshi, and Gando, Satoshi

Subjects
macromolecular substances
Abstract

Table S1. Characteristics and in-hospital mortality of patients with severe sepsis according to 11 sites of infection (nâ =â 1184). Features and in-hospital mortality of patients with severe sepsis according to 11 infection sites. (DOCX 27 kb)

Published
2019
Full Text
View/download PDF

22. Additional file 2: of Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan

Author

Abe, Toshikazu, Ogura, Hiroshi, Kushimoto, Shigeki, Shiraishi, Atsushi, Sugiyama, Takehiro, Deshpande, Gautam, Uchida, Masatoshi, Nagata, Isao, Daizoh Saitoh, Seitaro Fujishima, Mayumi, Toshihiko, Hifumi, Toru, Shiino, Yasukazu, Taka-Aki Nakada, Tarui, Takehiko, Otomo, Yasuhiro, Okamoto, Kohji, Umemura, Yutaka, Kotani, Joji, Sakamoto, Yuichiro, Sasaki, Junichi, Shin-Ichiro Shiraishi, Takuma, Kiyotsugu, Tsuruta, Ryosuke, Hagiwara, Akiyoshi, Yamakawa, Kazuma, Masuno, Tomohiko, Naoshi Takeyama, Yamashita, Norio, Ikeda, Hiroto, Ueyama, Masashi, Fujimi, Satoshi, and Gando, Satoshi

Abstract

Table S2. Characteristics of patients with sepsis according to seven major infection sites (nâ =â 1184). Additional features of patients with sepsis according to seven major sites of infection. (DOCX 29 kb)

Published
2019
Full Text
View/download PDF

23. Additional file 3: of Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan

Author

Abe, Toshikazu, Ogura, Hiroshi, Kushimoto, Shigeki, Shiraishi, Atsushi, Sugiyama, Takehiro, Deshpande, Gautam, Uchida, Masatoshi, Nagata, Isao, Daizoh Saitoh, Seitaro Fujishima, Mayumi, Toshihiko, Hifumi, Toru, Shiino, Yasukazu, Taka-Aki Nakada, Tarui, Takehiko, Otomo, Yasuhiro, Okamoto, Kohji, Umemura, Yutaka, Kotani, Joji, Sakamoto, Yuichiro, Sasaki, Junichi, Shin-Ichiro Shiraishi, Takuma, Kiyotsugu, Tsuruta, Ryosuke, Hagiwara, Akiyoshi, Yamakawa, Kazuma, Masuno, Tomohiko, Naoshi Takeyama, Yamashita, Norio, Ikeda, Hiroto, Ueyama, Masashi, Fujimi, Satoshi, and Gando, Satoshi

Subjects
macromolecular substances
Abstract

Table S3. Initial antibiotic treatment administered to patients with severe sepsis (nâ =â 1140). (DOCX 28 kb)

Published
2019
Full Text
View/download PDF

24. Primary success of electrical cardioversion for new-onset atrial fibrillation and its association with clinical course in non-cardiac critically ill patients: sub-analysis of a multicenter observational study.

Author

Shima, Nozomu, Miyamoto, Kyohei, Kato, Seiya, Yoshida, Takuo, Uchino, Shigehiko, on behalf of the AFTER-ICU study group, Yoshida, Tomonao, Nashiki, Hiroshi, Suzuki, Hajime, Takahashi, Hiroshi, Kishihara, Yuki, Nagasaki, Shinya, Okazaki, Tomoya, Katayama, Shinshu, Sakuraya, Masaaki, Ogura, Takayuki, Inoue, Satoki, Uchida, Masatoshi, Osaki, Yuka, and Kuriyama, Akira

Subjects
ATRIAL fibrillation, ELECTRIC countershock, CRITICALLY ill, ADULTS, INTENSIVE care units
Abstract

Background: Electrical cardioversion (ECV) is widely used to restore sinus rhythm in critically ill adult patients with atrial fibrillation, although its prognostic value is uncertain. This study aims to elucidate the clinical meaning of successful ECV. Methods: This is a sub-analysis of the AFTER-ICU study, a multicenter prospective study with a cohort of 423 adult non-cardiac patients with new-onset atrial fibrillation (AF). Patients that underwent ECV within 7 days after initial onset of AF were included in the sub-analysis. We compared intensive care unit (ICU) and overall hospital mortality, survival time within 30 days, cardiac rhythm at ICU discharge, and the length of ICU and overall hospital stay between patients whose sinus rhythm was restored immediately after the first ECV session (primary success group) and those in whom it was not restored (unsuccessful group). To find the factors related to the primary success of ECV, we also compared patient characteristics, the delivered energy, and pretreatment. Results: Sixty-five patients received ECV and were included in this study. Although 35 patients (54%) had primary success, recurrence of AF occurred in 24 of these patients (69%). At ICU discharge, three patients still had AF in the unsuccessful group, but no patients in the primary success group still had AF. ICU mortality was 34% in the primary success group and 17% in the unsuccessful group (P = 0.10). Survival time within 30 days did not differ between the groups. Delivered energy and pretreatment were not associated with primary success of ECV. Conclusions: The primary success rate of ECV for new-onset AF in adult non-cardiac ICU population was low, and even if it succeeded, the subsequent recurrence rate was high. Primary success of ECV did not affect the rate of mortality. Pretreatment and delivered energy were not associated with the primary success of ECV. Trial registration: UMIN clinical trial registry, the Japanese clinical trial registry (registration number: UMIN000026401, March 31, 2017). [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

26. Additional file 1: of Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries

Author

Abe, Toshikazu, Madotto, Fabiana, Tài Pham, Nagata, Isao, Uchida, Masatoshi, Tamiya, Nanako, Kiyoyasu Kurahashi, Bellani, Giacomo, and Laffey, John

Subjects
respiratory tract diseases
Abstract

Table S1. Additional baseline characteristics in patients with tracheostomy and no tracheostomy (n = 2377). BMI, body mass index; ICU, intensive care unit; ER, emergency room; COPD, chronic obstructive pulmonary disease; NYHA, New York heart association; AHRF, Acute hypoxemic respiratory failure; ARDS, acute respiratory distress syndrome; TRALI, transfusion-related acute lung injury; A/C, assist control; PC, pressure control; BIPAP, bilevel positive airway pressure APRV, airway pressure release ventilation; SIMV, synchronized intermittent mandatory ventilation, PRVC, pressure-regulated volume control; PSV, pressure support ventilation; HFO, high-frequency oscillation; CPAP, continuous positive airway pressure IBW, ideal body weight; PEEP, positive end-expiratory pressure; ECMO, extracorporeal membrane oxygenation; SOFA, sequential organ failure assessment. Missing data: source of admission to ICU = 1, Chest x-ray/CT scan number = 1. (DOCX 27 kb)

Published
2018
Full Text
View/download PDF

27. Additional file 2: of Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries

Author

Abe, Toshikazu, Madotto, Fabiana, Tài Pham, Nagata, Isao, Uchida, Masatoshi, Tamiya, Nanako, Kiyoyasu Kurahashi, Bellani, Giacomo, and Laffey, John

Abstract

Table S2 compares outcomes between early (within 7 days of ICU admission) and late (8 days and later) thoracotomy (n = 280). SD, standard deviation; ICU, intensive care unit; Q1–Q3; 25%–75% interquartile. Missing data: days of mechanical ventilation = 37; days of mechanical ventilation in patient alive at hospital discharge (90 days) = 139; length of ICU stay in patient alive at ICU discharge (90 days) = 58; length of hospital stay = 19; length of hospital stay in patient alive at ICU discharge (90 days) = 87; ICU, 28-day, 60-day, and 90-day mortality = 1. Participants were adult patients (≥ 18 years) with severe or moderate ARDS who received mechanical ventilation and had tracheostomy. Participants were excluded if they had made the decision to withhold/withdraw treatment; if they had been transferred from another hospital with invasive mechanical ventilation; if they received tracheostomy on the first day of the study period and had been on invasive mechanical ventilation for 6 days or more; or if they had been discharged from the ICU or died in the ICU within 7 days. Length of ICU and hospital stay were calculated from their admission to discharge. Mortality was calculated from day 7 to patient discharge. Days of mechanical ventilation, length of ICU stay, and length of hospital stay were compared using linear regression models, and mortality using logistic regression models. (DOCX 17 kb)

Published
2018
Full Text
View/download PDF

28. 1413

Author

Abe, Toshikazu, primary, Aoki, Makoto, additional, Deshpande, Gautam, additional, Sugiyama, Takehiro, additional, Iwagami, Masao, additional, Uchida, Masatoshi, additional, Nagata, Isao, additional, Saitoh, Daizoh, additional, and Tamiya, Nanako, additional

Published
2019
Full Text
View/download PDF

29. Prognostic impact of sustained new-onset atrial fibrillation in critically ill patients.

Author

Yoshida, Takuo, Uchino, Shigehiko, Sasabuchi, Yusuke, Hagiwara, Yasuhiro, the AFTER-ICU study group, Yoshida, Tomonao, Nashiki, Hiroshi, Suzuki, Hajime, Takahashi, Hiroshi, Kishihara, Yuki, Nagasaki, Shinya, Okazaki, Tomoya, Katayama, Shinshu, Sakuraya, Masaaki, Ogura, Takayuki, Inoue, Satoki, Uchida, Masatoshi, Osaki, Yuka, Kuriyama, Akira, and Irie, Hiromasa

Subjects
ATRIAL fibrillation, CRITICALLY ill, HOSPITAL mortality, INTENSIVE care units, DOSE-response relationship in biochemistry, NONPARAMETRIC statistics, TIME, PROGNOSIS, DISEASE incidence, CATASTROPHIC illness, CHI-squared test, ODDS ratio, LONGITUDINAL method, DISEASE complications
Abstract

Purpose: The development of new-onset atrial fibrillation (AF) in critically ill patients may be associated with poor outcomes. However, it is unknown whether sustained new-onset AF contributes to worse outcome. The aim of this study was to assess whether sustained new-onset AF is associated with stroke and death and to look for a possible dose-response relationship between AF duration and death.Methods: In a prospective cohort study conducted in 32 intensive care units in Japan from 2017 to 2018, we enrolled adult patients with new-onset AF. We compared patients with AF duration longer than 48 h with those with AF duration shorter than 48 h. To assess a dose-response relationship between AF duration and hospital mortality, we conducted landmark analysis and time-dependent Cox regression analysis.Results: Among a total of 423 new-onset AF patients, hospital mortality was 25%, and the incidence of in-hospital stroke was 4.6%. AF duration longer than 48 h was not independently associated with hospital mortality (adjusted odds ratio: 1.52; 95% Confidence Interval: 0.87-2.64). The incidence of in-hospital stroke was 7.6% in patients with AF duration longer than 48 h and 3.8% in those with AF duration shorter than 48 h (p = 0.154). When analyzing time more continuously, we observed a time-dependent association between AF duration and hospital mortality (p = 0.005 by landmark analysis and p = 0.019 by Cox analysis).Conclusions: Sustained new-onset AF was time-dependently associated with hospital mortality in ICU patients, albeit with some uncertainty since AF duration longer than 48 h was not independently associated with in-hospital death or stroke. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

32. Total syntheses of (+)- and (-)-pestalotiopsin A

Author

Ken-ichi Takao, Hayakawa, Nobuhiko, Yamada, Reo, Yamaguchi, Taro, Saegusa, Hiroshi, Uchida, Masatoshi, Samejima, Suguru, and Tadano, Kin-ichi

Subjects
Ring formation (Chemistry) -- Analysis, Ketenes (Class of compounds) -- Chemical properties, Ketenes (Class of compounds) -- Structure, Oxidation-reduction reaction -- Analysis, Palladium catalysts -- Chemical properties, Sesquiterpenes -- Chemical properties, Sesquiterpenes -- Structure, Stereochemistry -- Analysis, Biological sciences, Chemistry
Abstract

Enantioselective total synthesis of both enantiomers of caryophyllene-type sesquiterpenoid pestalotiopsin A is achieved, thus indicating the absolute stereochemistry of natural (+)-pestalotiospin A. The highlights of the synthesis have included the [2+2] cyloaddition of N-propioloyl Oppolzer's camphorsultam and ketene dialkyl acetal and a palladium-catalyzed reduction of allylic mesylate with retention of the E configuration.

Published
2009

37. [Untitled]

Author

Yui Yamaoka, Uchida Masatoshi, Isao Nagata, Nanako Tamiya, and Toshikazu Abe

Subjects
medicine.medical_specialty, business.industry, Emergency medicine, medicine, Critical Care and Intensive Care Medicine, business, Out of hospital cardiac arrest
Published
2015

39. Total Syntheses of (+)- and (−)-Pestalotiopsin A

Author

Takao, Ken-ichi, primary, Hayakawa, Nobuhiko, additional, Yamada, Reo, additional, Yamaguchi, Taro, additional, Saegusa, Hiroshi, additional, Uchida, Masatoshi, additional, Samejima, Suguru, additional, and Tadano, Kin-ichi, additional

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results